Pharmaceutical Executive-01-01-2020

Pharmaceutical Executive

Sharing the Pricing Stage in 2020

January 15, 2020

From the Editor

40

1

While drug pricing remains a top topic in the media at large and worthy of continuous exploration, we shift away in our latest pharma trends report, instead spotlighting seven key themes that we think are a bit less unpredictable in the months ahead.

Paving Bayer’s Future Path

January 14, 2020

Features

40

1

Led in part by its new head of the Americas business, Sebastian Guth, Bayer went all in in 2019 on expanding pursuits in science and discovery, striking deals with 11 digital health startups and upping investment in disease-detection programs and patient engagement and education.

A Happy New Year for European Pharma Policy?

January 12, 2020

Columns

40

1

What to make of new momentum in advancing health agenda.

Deeper Dive: Gene Therapy Manufacturing

January 01, 2020

Features

40

1

Hari Pujar, chief technology officer of Spark Therapeutics, discusses the unique manufacturing and scale-up challenges involved with cell and gene therapy production.

Pharmaceutical Executive, January 2020 Issue (PDF)

January 01, 2020

Issue PDF

40

1

Click the title above to open the Pharmaceutical Executive January 2020 issue in an interactive PDF format.

Country Report: China

January 01, 2020

Special Sponsored Section

40

1

In China’s new reform-driven and fast-moving environment for healthcare innovation, intense market pressures and fierce competition will ultimately push all stakeholders to evolve their strategies-or face extinction.